Family history of disease

Family history of disease has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Aug 25, 2022: “Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on family history of disease

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“a five-fold increase in those with a family history of disease versus those without (25% versus 5%)”
Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosisThe European respiratory journal2022doi:10.1183/13993003.00577-2022
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: AstraZeneca and others
  • 1 of 1 finding with company ties
  • Humans1

What did studies of family history of disease find?

1

Studies of family history of disease measured one outcome, Rare qualifying variants.

Rare qualifying variants

upin humans1

1 study
  1. Family history of disease is linked with higher rare qualifying variants in humans (five-fold (25% versus 5%)).

    “a five-fold increase in those with a family history of disease versus those without (25% versus 5%)”

    Humans

    Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis

    The European respiratory journal

Latest